Lupus happens when the immune system loses its ability to distinguish the body’s own cells from foreign invaders and begins attacking healthy tissue. No single cause explains every case. Instead, lupus develops from a collision of genetic vulnerability, hormonal biology, viral infections, and environmental exposures that together push the immune system past a tipping point. About 204,000 people in the United States have systemic lupus, and 9 out of 10 of them are women.
Genetics Load the Gun
Lupus runs in families, but it’s not a simple inheritance. Identical twins, who share the same DNA, don’t always both develop the disease, which tells researchers that genes alone aren’t enough. What genetics do is raise the baseline risk by shaping how your immune system behaves.
The strongest genetic link involves a cluster of genes called HLA, which help immune cells identify what belongs to the body and what doesn’t. Variations in these genes can make the immune system more prone to confusion. The second-strongest genetic risk factor is a gene called IRF5, which regulates immune activation. In people with certain IRF5 variants, the protein it produces becomes overactive, essentially leaving the immune system in a heightened state where it’s more likely to turn on the body’s own tissues.
These genes don’t work alone. They interact with immune sensors (called toll-like receptors) that normally detect invading bacteria and viruses by recognizing foreign DNA and RNA. In lupus, those same sensors can be triggered by the body’s own genetic material, mistaking it for a threat. This creates a false alarm that spirals into chronic inflammation.
Why Women Are Far More Likely to Get Lupus
Women of childbearing age, roughly 15 to 44, face the highest risk. Black and American Indian/Alaska Native women are two to three times more likely than white women to develop the disease. For decades, researchers assumed estrogen was the primary explanation for the sex gap. The real story turns out to be more surprising.
A 2024 study from Stanford Medicine identified a molecular process unique to female cells. Every woman’s body must shut down one of her two X chromosomes in each cell to avoid producing too much protein. This silencing is carried out by a long molecule called Xist, which coats and deactivates one X chromosome. The problem is that Xist, in doing its job, creates unusual molecular structures: tangles of RNA, proteins, and DNA that the immune system has never been trained to tolerate. These structures can trigger the production of antibodies directed against the body itself.
When researchers engineered male mice to produce Xist, those males developed lupus-like autoimmunity at rates approaching those of females. This finding reframed the female vulnerability to lupus as something built into the basic biology of having two X chromosomes, not simply a hormonal effect. It also revealed a diagnostic blind spot: standard antibody tests were historically developed using male cell lines that produce no Xist, meaning a major source of autoimmune antibodies in women has gone undetected.
The Epstein-Barr Virus Connection
Nearly all adults carry the Epstein-Barr virus (EBV), the virus behind mononucleosis. In most people, the virus infects a tiny number of immune cells called B cells and goes dormant. Fewer than 1 in 10,000 B cells carry the virus in a healthy person. In people with lupus, that number jumps to about 1 in 400, a 25-fold increase.
The virus doesn’t just sit quietly in those cells. Even in its dormant state, EBV occasionally prompts its host B cell to produce a viral protein called EBNA2. Stanford researchers found that EBV-infected B cells can essentially become rogue commanders, reprogramming other uninfected immune cells to launch widespread attacks on the body’s own tissues. The infected B cells activate neighboring B cells, which then produce antibodies targeting normal proteins and DNA throughout the body. This chain reaction can convert a small viral foothold into a systemic autoimmune assault.
Environmental Triggers That Set Off Flares
In someone with genetic and biological susceptibility, environmental exposures can be the final push. Ultraviolet light is one of the most well-documented triggers. Research from the Hospital for Special Surgery has shown that in people with lupus, the lymphatic vessels in the skin don’t drain fluid and immune signals properly. When UV radiation damages skin cells, the debris lingers longer than it should. This delayed clearance sends abnormal signals to nearby lymph nodes, where they activate the very immune cells that drive lupus flares. In lupus-prone mice exposed to UV radiation, researchers found measurably more fluid trapped in the skin, confirming the drainage problem. When they manually improved lymphatic flow, the number of disease-driving immune cells dropped.
Silica dust exposure (common in mining, construction, and agriculture) and cigarette smoking also raise lupus risk. Certain medications can trigger a separate condition called drug-induced lupus. The most common culprits include isoniazid (a tuberculosis drug), hydralazine (for high blood pressure), and TNF-alpha inhibitors used for other autoimmune conditions. Cancer immunotherapy drugs can also cause it. Drug-induced lupus typically resolves after stopping the medication, unlike systemic lupus.
The Cleanup Problem at the Center of Lupus
One of the most fundamental breakdowns in lupus involves how the body handles its own dead cells. Billions of cells die naturally every day through a controlled process, and the immune system is supposed to clean them up quickly and quietly. In lupus, this cleanup system fails.
When dead cells aren’t cleared efficiently, they begin to break apart in an uncontrolled way, spilling their internal contents, including DNA and proteins that are normally hidden inside the cell. Immune cells called neutrophils can also release their genetic material in web-like structures (a defense normally aimed at trapping bacteria). In lupus, these webs accumulate because the body can’t break them down fast enough. The exposed DNA and proteins get picked up by the immune system, which treats them as foreign. Specialized immune cells present this material to B cells, which then produce antibodies against the body’s own nuclear components. Those antibodies bind to more cellular debris, forming clumps called immune complexes that deposit in tissues and drive inflammation in the kidneys, joints, skin, and other organs.
The Interferon Cycle That Keeps It Going
Once lupus is initiated, a self-reinforcing loop makes it persist. At the center of this loop is a signaling molecule called interferon-alpha, part of the body’s antiviral defense system. In lupus, immune complexes (antibodies bound to cellular debris) are swallowed by a type of immune cell that then pumps out interferon-alpha in large quantities.
Interferon-alpha does several things simultaneously that worsen the disease. It matures other immune cells and makes them better at presenting the body’s own material as a target. It pushes B cells to produce more antibodies and to become more aggressive in their response. And it feeds back on the cells producing it, causing them to release even more interferon. This creates a cycle: more antibodies lead to more immune complexes, which trigger more interferon, which activates more immune cells, which produce more antibodies. Breaking this cycle is one of the central goals of lupus treatment.
Epigenetic Changes Bridge Genes and Environment
Epigenetics helps explain how environmental exposures translate into immune dysfunction without changing your actual DNA. Chemical tags on DNA and the proteins that package it act like volume knobs, turning genes up or down. In lupus, these tags are altered in immune cells in ways that increase self-reactivity. When researchers treated a type of immune cell with a compound that strips away one of these chemical tags (called a methyl group), the cells became more likely to attack the body’s own tissues. UV light, infections, smoking, and other exposures can all shift these epigenetic marks over time, gradually reprogramming immune cells toward autoimmunity in people who are already genetically susceptible.
This layered picture, where genes set the stage, hormones and X-chromosome biology shape vulnerability, viruses and environmental exposures provide the spark, and epigenetic changes lock in the dysfunction, explains why lupus doesn’t have a single cause. It also explains why the disease varies so much from person to person: different combinations of these factors produce different patterns of immune activation, different organs affected, and different levels of severity.